Title : Influence of NAT2 polymorphisms on sulfamethoxazole pharmacokinetics in renal transplant recipients.

Pub. Date : 2012 Feb

PMID : 22106207






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Influence of NAT2 polymorphisms on sulfamethoxazole pharmacokinetics in renal transplant recipients. Sulfamethoxazole N-acetyltransferase 2 Homo sapiens
2 The objective of this study was to examine the impact of N-acetyltransferase 2 (NAT2) and CYP2C9 polymorphisms on the pharmacokinetics of SMX in 118 renal transplant recipients. Sulfamethoxazole N-acetyltransferase 2 Homo sapiens
3 The objective of this study was to examine the impact of N-acetyltransferase 2 (NAT2) and CYP2C9 polymorphisms on the pharmacokinetics of SMX in 118 renal transplant recipients. Sulfamethoxazole N-acetyltransferase 2 Homo sapiens
4 SMX plasma concentrations were affected by NAT2 polymorphisms and renal dysfunction. Sulfamethoxazole N-acetyltransferase 2 Homo sapiens